NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 194)
Posted On: 11/07/2018 5:26:18 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Appoints Senior VP and Chief Commercial Officer Bradford A. Young, Ph.D.
Pressure BioSciences (OTCQB: PBIO) today announced appointment of its Sr. Vice President and Chief Commercial Officer Dr. Bradford A. Young, effective Monday, November 5, 2018. In this new key position, Dr. Young’s responsibilities will include assessing multiple major opportunities in new and divergent markets, as well as optimizing strategy and commercialization priorities for the company. In addition to strategic planning, Dr. Young will build customer adoption and accelerate revenue growth through driving the execution of critical partnering and commercialization programs.
Young stated in the news release, “I am excited to join Pressure BioSciences at a time when I can help to develop and then lead commercial strategies to expand the utility and market penetration of our patented, pressure-based technology platforms, through customer-focused efforts to drive adoption and sales expansion. It is highly motivating to join a company driven by such cutting-edge scientific innovations, already spanning multiple major application areas, and supported by a diverse array of products and services to multiple customer segments.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) today announced appointment of its Sr. Vice President and Chief Commercial Officer Dr. Bradford A. Young, effective Monday, November 5, 2018. In this new key position, Dr. Young’s responsibilities will include assessing multiple major opportunities in new and divergent markets, as well as optimizing strategy and commercialization priorities for the company. In addition to strategic planning, Dr. Young will build customer adoption and accelerate revenue growth through driving the execution of critical partnering and commercialization programs.
Young stated in the news release, “I am excited to join Pressure BioSciences at a time when I can help to develop and then lead commercial strategies to expand the utility and market penetration of our patented, pressure-based technology platforms, through customer-focused efforts to drive adoption and sales expansion. It is highly motivating to join a company driven by such cutting-edge scientific innovations, already spanning multiple major application areas, and supported by a diverse array of products and services to multiple customer segments.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼